Inhibition of CYP2A6-mediated nicotine metabolism can reduce cigarette smoking. We sought potent and selective CYP2A6 inhibitors to be used as leads for drugs useful in smoking reduction therapy, by evaluating CYP2A6 inhibitory effect of novel formyl, alkyl amine or carbonitrile substituted aromatic core structures. The most potent CYP2A6 inhibitors were thienopyridine-2-carbaldehyde, benzothienophene-3-ylmethanamine, benzofuran-5-carbaldehyde and indole-5-carbaldehyde, with IC50 values below 0.5 μM for coumarin 7-hydroxylation. Nicotine oxidation was effectively inhibited in vitro by two alkyl amine compounds and benzofuran-5-carbonitrile. Some of these molecules could serve as potential lead molecules when designing CYP2A6 inhibitory drugs for smoking reduction therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2014.10.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Machine Learning-Based Prediction of the Inhibitory Activity of Chemical Substances Against Rat and Human Cytochrome P450s.
Chem Res Toxicol
November 2024
Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 4228526, Japan.
The prediction of cytochrome P450 inhibition by a computational (quantitative) structure-activity relationship approach using chemical structure information and machine learning would be useful for toxicity research as a simple and rapid tool. However, there are few models focusing on the species differences between rat and human in the P450s inhibition. This study aimed to establish models to classify chemical substances as inhibitors or non-inhibitors of various rat and human P450s, using only molecular descriptors.
View Article and Find Full Text PDFDevelopment of a high throughput cytochrome P450 ligand-binding assay.
J Biol Chem
October 2024
Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA; Departments of Medicinal Chemistry, and Biological Chemistry and the Programs in Chemical Biology and Biophysics, University of Michigan, Ann Arbor, Michigan, USA. Electronic address:
Article Synopsis
- * Traditional methods for studying these interactions are time-consuming and resource-intensive, but a new semi-automated high-throughput screening assay allows for significantly faster testing with less protein and solvents, validated for different substrate interactions.
- * The assay was used to screen a library of imidazole compounds across three different cytochrome P450 enzymes, yielding unique binding profiles that can help develop pharmacophores and identify potential inhibitors or new drug candidates while enhancing computational predictions.
Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6.
Int J Mol Sci
July 2024
Department of ChemInformatics, NovaMechanics Ltd., Nicosia 1070, Cyprus.
Tobacco smoking has been highlighted as a major health challenge in modern societies. Despite not causing death directly, smoking has been associated with several health issues, such as cardiovascular diseases, respiratory disorders, and several cancer types. Moreover, exposure to nicotine during pregnancy has been associated with adverse neurological disorders in babies.
View Article and Find Full Text PDFStudy on Cytochrome P450 Metabolic Profile of Paclitaxel on Rats using QTOF-MS.
Curr Drug Metab
November 2024
Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 600 Yi Shan Road, Shanghai, 200233, P. R. China.
Background: Paclitaxel (PTX) is a key drug used for chemotherapy for various cancers. The hydroxylation metabolites of paclitaxel are different between humans and rats. Currently, there is little information available on the metabolic profiles of CYP450 enzymes in rats.
View Article and Find Full Text PDFInhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes.
Eur J Drug Metab Pharmacokinet
September 2024
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, P.O. Box 33516, Kafrelsheikh, Egypt.
Background And Objectives: Both AW-9A (coumarin derivative) and WES-1 (sulfonamide derivative) were designed and synthesized as potential selective carbonic anhydrase inhibitors and were tested for anticancer activity. This study was undertaken to investigate their potential inhibitory effects on the major human cytochrome P450 (CYP) drug-metabolizing enzymes.
Methods: Specific CYP probe substrates and validated analytical methods were used to measure the activity of the tested CYP enzymes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!